Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITONAVIR vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITONAVIR vs RITUXIMAB: Safety Overview

Metric RITONAVIR RITUXIMAB
Total FAERS Reports 11,980 178,614
Deaths Reported 1,190 28,910
Death Rate 9.9% 16.2%
Hospitalizations 2,925 54,631
Average Patient Age 43.8 yrs 54.6 yrs
% Female Patients 43.8% 64.3%
FDA Approval Date Dec 3, 2020 N/A
Manufacturer AbbVie Inc. Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription